Inspire Medical Systems
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
105.0038.2225.2418.97
Price/Sales ratio
2.592.171.791.52
Earnings per Share (EPS)
$0.85$2.35$3.56$4.74

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-14.59-16.80-19.24-28.22-53.13-85.73-149.18-157.54-281.80-144.50-69.43
Price/Sales ratio
38.8518.9511.7912.1721.5242.5026.8717.339.5425.7116.85
Price/Book Value ratio
N/A-47.11227.083.7512.6321.3427.3814.2510.4113.998.19
Price/Cash Flow ratio
-13.98-17.34-21.34-32.95-53.78-92.45-311.75611.17241.79599.95-43.36
Price/Free Cash Flow ratio
-13.77-17.05-20.79-32.51-49.64-88.36-253.042.85K5.82K2.80K-41.07
Price/Earnings Growth ratio
N/A1.301.50-1.837.97-1.515.02-40.435.1237.533.06
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
64.94%76.22%78.93%80.12%83.37%84.72%85.74%83.78%84.54%83.71%81.74%
Operating Profit Margin
-247.10%-105.02%-56.01%-40.27%-42.53%-48.71%-17.07%-11.66%-6.44%-17.50%-41.40%
Pretax Profit Margin
-266.31%-112.78%-61.29%-43.14%-40.46%-49.47%-17.98%-10.85%-3.18%-17.61%-41.80%
Net Profit Margin
-266.31%-112.78%-61.29%-43.14%-40.51%-49.57%-18.01%-11.00%-3.38%-17.79%-41.82%
Effective Tax Rate
-7.13%-6.87%-10.25%-8.49%-0.12%-0.20%-0.17%-1.38%-6.26%-1.02%-0.16%
Return on Assets
N/A-141.26%-69.78%-10.90%-18.34%-20.34%-14.24%-7.94%-3.12%-8.50%-14.62%
Return On Equity
N/A280.38%-1179.98%-13.30%-23.77%-24.89%-18.35%-9.04%-3.69%-13.54%-18.54%
Return on Capital Employed
N/A-296.13%-89.18%-10.78%-21.22%-21.57%-15.70%-9.44%-6.72%-9.38%-16.00%
Liquidity Ratios
Current Ratio
N/AN/AN/A17.8610.1213.02N/AN/AN/A8.6611.57
Quick Ratio
N/A1.222.8517.629.7712.616.088.467.168.3711.19
Cash ratio
N/A0.911.258.721.359.195.197.212.377.215.03
Days of Sales Outstanding
N/A46.4649.2948.0958.4179.2853.4554.7952.5082.7853.25
Days of Inventory outstanding
N/A313.59222.5996.80156.08175.61188.9865.61128.0698.68165.84
Operating Cycle
N/A360.05271.88144.90214.49254.89242.43120.41180.57119.09234.69
Days of Payables Outstanding
N/A109.64181.83124.46119.29149.30127.94148.21146.78222.89121.87
Cash Conversion Cycle
N/A250.4190.0520.4495.19105.58114.49-27.8033.78-115.77100.39
Debt Ratios
Debt Ratio
N/A1.190.650.120.130.080.110.010.030.120.12
Debt Equity Ratio
N/A-2.3711.090.150.170.100.140.010.040.130.14
Long-term Debt to Capitalization
N/A2.140.910.130.140.090.090.010.040.010.12
Total Debt to Capitalization
N/A1.720.910.130.140.090.120.010.04N/A0.12
Interest Coverage Ratio
N/AN/AN/A-6.16-16.46-26.55N/AN/AN/A-28.17-21.50
Cash Flow to Debt Ratio
N/A-1.14-0.95-0.74-1.33-2.14-0.591.530.99N/A-1.04
Company Equity Multiplier
N/A-1.9816.901.221.291.221.281.131.181.131.26
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.77-1.09-0.55-0.36-0.40-0.45-0.080.020.030.04-0.38
Free Cash Flow / Operating Cash Flow Ratio
1.011.011.021.011.081.041.230.210.040.211.06
Cash Flow Coverage Ratio
N/A-1.14-0.95-0.74-1.33-2.14-0.591.530.99N/A-1.04
Short Term Coverage Ratio
N/A-5.42N/AN/AN/AN/A-2.18N/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A